As of 2026-10-06, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (123.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.03 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -1046.9%.
The range of the Relative Valuation is (113.40) - (131.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (113.40) - (131.99) | (123.37) |
| Upside | -970.3% - -1113.0% | -1046.9% |
| Date | P/E |
| 2026-10-01 | -2.91 |
| 2026-09-30 | -3.02 |
| 2026-09-29 | -3.02 |
| 2026-09-28 | -3.19 |
| 2026-09-25 | -3.05 |
| 2026-09-24 | -3.11 |
| 2026-09-23 | -2.93 |
| 2026-09-22 | -3.17 |
| 2026-09-21 | -3.24 |
| 2026-09-18 | -3.53 |
| 2026-09-17 | -3.73 |
| 2026-09-16 | -3.44 |
| 2026-09-15 | -3.49 |
| 2026-09-14 | -3.37 |
| 2026-09-11 | -3.25 |
| 2026-09-10 | -3.08 |
| 2026-09-09 | -3.25 |
| 2026-09-08 | -3.45 |
| 2026-09-04 | -3.49 |
| 2026-09-03 | -3.43 |
| 2026-09-02 | -3.69 |
| 2026-09-01 | -3.58 |
| 2026-08-31 | -3.25 |
| 2026-08-28 | -3.35 |
| 2026-08-27 | -3.56 |
| 2026-08-26 | -3.49 |
| 2026-08-25 | -3.40 |
| 2026-08-24 | -3.16 |
| 2026-08-21 | -2.97 |
| 2026-08-20 | -2.42 |
| 2026-08-19 | -2.27 |
| 2026-08-18 | -1.81 |
| 2026-08-17 | -1.79 |
| 2026-08-14 | -1.81 |
| 2026-08-13 | -1.73 |
| 2026-08-12 | -1.68 |
| 2026-08-11 | -1.66 |
| 2026-08-10 | -1.55 |
| 2026-08-07 | -1.63 |
| 2026-08-06 | -1.34 |
| 2026-08-05 | -1.38 |
| 2026-08-04 | -1.37 |
| 2026-08-03 | -1.32 |
| 2026-07-31 | -1.27 |
| 2026-07-30 | -1.31 |
| 2026-07-29 | -1.28 |
| 2026-07-28 | -1.27 |
| 2026-07-27 | -1.27 |
| 2026-07-24 | -1.22 |
| 2026-07-23 | -1.28 |